Roles to support collaboration
University College London
Translational Research Office
The UCL Translational Research Office (TRO) provides integrated support for translational research, drug discovery and industrial partnerships, across the School of Life and Medical Sciences and wider UCL community. Scientists with experience of working in both industry and academia staff the office. They provide practical help and project management expertise to academics wishing to explore the translational pathway for their research.
The office comprises of three core groups, each offering specialised support and advice: Translational Research Group; Industrial Partnerships Group; and the Drug Discovery Group (DDG). The groups work with colleagues in UCL Enterprise and UCL Business to facilitate the interaction and progression of projects from basic hypotheses to the clinic. They also help to secure external and internal funding streams and manage the growing portfolio of translational projects. The groups lead and manage strategic, long-term and high-value collaborations with industry partners that enhance UCL’s ability to translate its biomedical research towards patient benefit.
The DDG provides theoretical and practical expertise to support the progression of selected UCL projects. Established in 2012 and staffed initially by experienced medicinal chemists, the group is expanding and establishing biological assay facilities to support their translational activities. Using the strong industry links established within the group, they enable collaborative activities for UCL academics. These include sourcing compound libraries, facilitating links with other groups and companies, and providing advice on suitable funding sources and grant applications.
The DDG established the Innovative Therapeutics Postdoctoral Training Programme. This is an industry facing two-year programme providing practical research experience through of a series of secondments and projects in academic and industrial drug discovery laboratory environments. Members of the group teach on undergraduate and MSc courses, and contribute to the development of new training approaches. They lead the current initiative to provide on-line CPD courses focused on innovative therapeutics.
Further information: UCL Translational Research Office